Research ArticleCancer

BET inhibition increases βIII-tubulin expression and sensitizes metastatic breast cancer in the brain to vinorelbine

See allHide authors and affiliations

Science Translational Medicine  26 Aug 2020:
Vol. 12, Issue 558, eaax2879
DOI: 10.1126/scitranslmed.aax2879

Log in to view full text

Log in through your institution

Log in through your institution

Stay Connected to Science Translational Medicine

Navigate This Article